Sign in

CIK 0000313143

  • Large accelerated filer

HAEMONETICS CORP

Sign in to watch
Ticker
HAE
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Apr 3
Incorporated
MA
Entity type
Operating
EIN
042882273
Phone
+1 781-848-7100
Business address
125 SUMMER STREET, BOSTON, MA, 02110
  1. 4 Open-market sale CFO & EVP Business Development sold 436 shares at $32.13 ($14,008)
  2. 4 Open-market sale Chief Operating Officer sold 278 shares at $31.75 ($8,826)
  3. 4 Open-market sale President, Global Markets sold 191 shares at $31.75 ($6,064)
  4. 4 Open-market sale EVP and Chief Legal Officer sold 250 shares at $31.75 ($7,937)
  5. 4 Open-market sale Chief Science and Technology sold 250 shares at $31.75 ($7,937)
  6. 4 Open-market sale VP Finance sold 162 shares at $31.75 ($5,143)
  7. 4 Open-market sale EVP, Global QA/RA sold 249 shares at $31.75 ($7,906)
  8. 4 Grant or award EVP, Global QA/RA acquired 3,909 shares (grant or award)
  9. 4 Grant or award EVP, Global Human Resources acquired 2,736 shares (grant or award)
  10. 4 Grant or award EVP and Chief Legal Officer acquired 3,323 shares (grant or award)
  11. 4 Grant or award CFO & EVP Business Development acquired 6,255 shares (grant or award)
  12. 4 Grant or award President, Global Markets acquired 3,909 shares (grant or award)
  13. 4 Grant or award Chief Science and Technology acquired 4,105 shares (grant or award)
  14. 4 Grant or award Chief Operating Officer acquired 9,774 shares (grant or award)
  15. 4 Grant or award EVP, Global Manufacturing acquired 4,222 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale President & CEO sold 6,569 shares at $35.15 ($230,900)
  18. 4 Open-market sale President & CEO sold 4,765 shares at $35.63 ($169,792)
  19. 4 Open-market sale CFO & EVP Business Development sold 4,902 shares at $38.49 ($188,688)
  20. 4 Open-market sale President & CEO sold 6,569 shares at $39.28 ($258,019)

Page 23 of 60 · 1,191 filings